Coya Therapeutics (COYA) EBT Growth (3y) (2025 - 2026)

Coya Therapeutics (COYA) EBT Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Oculis Holding AG 65,899.61 Bn 65,899.33 Bn - 9.34%
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.67 Bn 466.88 Bn 1.35 Bn 40.43%
5 Vertex Pharmaceuticals 122.32 Bn 115.07 Bn 2.59 Bn 12.01%
6 Regeneron Pharmaceuticals 70.04 Bn 61.29 Bn 3.31 Bn -1.05%
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.93 Bn 50.74 Bn 1.41 Bn 86.16%
9 Alnylam Pharmaceuticals 37.55 Bn 34.54 Bn 959.66 Mn 48.67%
10 Coya Therapeutics 98.05 Mn 47.33 Mn - -21.88%

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.88%
Dec 31, 2025 -41.82%
Sep 30, 2025 -22.24%
Jun 30, 2025 -20.93%
Mar 31, 2025 -62.58%